144 related articles for article (PubMed ID: 28437838)
1. Prognostic relevance of miR-124-3p and its target TP53INP1 in pediatric ependymoma.
Margolin-Miller Y; Yanichkin N; Shichrur K; Toledano H; Ohali A; Tzaridis T; Michowitz S; Fichman-Horn S; Feinmesser M; Pfister SM; Witt H; Tabori U; Bouffet E; Ramaswamy V; Hawkins C; Taylor MD; Yaniv I; Avigad S
Genes Chromosomes Cancer; 2017 Aug; 56(8):639-650. PubMed ID: 28437838
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and microRNA profile analysis for CD44 positive expression pediatric posterior fossa ependymoma.
Shu C; Wang Q; Yan X; Wang J
Clin Transl Oncol; 2018 Nov; 20(11):1439-1447. PubMed ID: 29704232
[TBL] [Abstract][Full Text] [Related]
3. Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.
Zakrzewska M; Fendler W; Zakrzewski K; Sikorska B; Grajkowska W; Dembowska-Bagińska B; Filipek I; Stefańczyk Ł; Liberski PP
PLoS One; 2016; 11(7):e0158464. PubMed ID: 27390862
[TBL] [Abstract][Full Text] [Related]
4. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
5. circCDYL Acts as a Tumor Suppressor in Triple Negative Breast Cancer by Sponging miR-190a-3p and Upregulating TP53INP1.
Wang S; Liu F; Ma H; Cui X; Yang S; Qin R
Clin Breast Cancer; 2020 Oct; 20(5):422-430. PubMed ID: 32741666
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G
Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733
[TBL] [Abstract][Full Text] [Related]
7. Pediatric ependymoma: GNAO1, ASAH1, IMMT and IPO7 protein expression and 5-year prognosis correlation.
Pérez-Ramírez M; García-Méndez A; Siordia-Reyes AG; Chavarría A; Gómez C; García-Hernández N
Clin Neurol Neurosurg; 2019 Nov; 186():105488. PubMed ID: 31505435
[TBL] [Abstract][Full Text] [Related]
8. Identification of microRNAs as potential prognostic markers in ependymoma.
Costa FF; Bischof JM; Vanin EF; Lulla RR; Wang M; Sredni ST; Rajaram V; Bonaldo Mde F; Wang D; Goldman S; Tomita T; Soares MB
PLoS One; 2011; 6(10):e25114. PubMed ID: 22053178
[TBL] [Abstract][Full Text] [Related]
9. Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma.
Calsina B; Castro-Vega LJ; Torres-Pérez R; Inglada-Pérez L; Currás-Freixes M; Roldán-Romero JM; Mancikova V; Letón R; Remacha L; Santos M; Burnichon N; Lussey-Lepoutre C; Rapizzi E; Graña O; Álvarez-Escolá C; de Cubas AA; Lanillos J; Cordero-Barreal A; Martínez-Montes ÁM; Bellucci A; Amar L; Fernandes-Rosa FL; Calatayud M; Aller J; Lamas C; Sastre-Marcos J; Canu L; Korpershoek E; Timmers HJ; Lenders JW; Beuschlein F; Fassnacht-Capeller M; Eisenhofer G; Mannelli M; Al-Shahrour F; Favier J; Rodríguez-Antona C; Cascón A; Montero-Conde C; Gimenez-Roqueplo AP; Robledo M
Theranostics; 2019; 9(17):4946-4958. PubMed ID: 31410193
[No Abstract] [Full Text] [Related]
10. miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas.
Braoudaki M; Lambrou GI; Giannikou K; Papadodima SA; Lykoudi A; Stefanaki K; Sfakianos G; Kolialexi A; Tzortzatou-Stathopoulou F; Tzetis M; Kitsiou-Tzeli S; Kanavakis E
Tumour Biol; 2016 Jul; 37(7):9887-97. PubMed ID: 26813564
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
[TBL] [Abstract][Full Text] [Related]
12. MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy.
Zhong X; Xie G; Zhang Z; Wang Z; Wang Y; Wang Y; Qiu Y; Li L; Bu H; Li J; Zheng H
Oncotarget; 2016 Sep; 7(38):61166-61182. PubMed ID: 27533459
[TBL] [Abstract][Full Text] [Related]
13. EZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian Pediatric Brain Tumor Consortium study.
Li AM; Dunham C; Tabori U; Carret AS; McNeely PD; Johnston D; Lafay-Cousin L; Wilson B; Eisenstat DD; Jabado N; Zelcer S; Silva M; Scheinemann K; Fryer C; Hendson G; Fotovati A; Hawkins C; Yip S; Dunn SE; Hukin J
Cancer; 2015 May; 121(9):1499-507. PubMed ID: 25586788
[TBL] [Abstract][Full Text] [Related]
14. Current and evolving knowledge of prognostic factors for pediatric ependymomas.
Andreiuolo F; Ferreira C; Puget S; Grill J
Future Oncol; 2013 Feb; 9(2):183-91. PubMed ID: 23414469
[TBL] [Abstract][Full Text] [Related]
15. MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells.
Wei Q; Li YX; Liu M; Li X; Tang H
IUBMB Life; 2012 Aug; 64(8):697-704. PubMed ID: 22730212
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients.
Nishimoto M; Nishikawa S; Kondo N; Wanifuchi-Endo Y; Hato Y; Hisada T; Dong Y; Okuda K; Sugiura H; Kato H; Takahashi S; Toyama T
Jpn J Clin Oncol; 2019 Jun; 49(6):567-575. PubMed ID: 30855679
[TBL] [Abstract][Full Text] [Related]
17. miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia.
Avigad S; Verly IR; Lebel A; Kordi O; Shichrur K; Ohali A; Hameiri-Grossman M; Kaspers GJ; Cloos J; Fronkova E; Trka J; Luria D; Kodman Y; Mirsky H; Gaash D; Jeison M; Avrahami G; Elitzur S; Gilad G; Stark B; Yaniv I
Genes Chromosomes Cancer; 2016 Apr; 55(4):328-39. PubMed ID: 26684414
[TBL] [Abstract][Full Text] [Related]
18. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
[TBL] [Abstract][Full Text] [Related]
19. TP53INP1 3'-UTR functions as a ceRNA in repressing the metastasis of glioma cells by regulating miRNA activity.
Wang Y; Lin G
Biotechnol Lett; 2016 Oct; 38(10):1699-707. PubMed ID: 27341836
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
